These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31619667)

  • 21. Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier.
    Di K; Lloyd GK; Abraham V; MacLaren A; Burrows FJ; Desjardins A; Trikha M; Bota DA
    Neuro Oncol; 2016 Jun; 18(6):840-8. PubMed ID: 26681765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stabilization effect of resin on the production of potent proteasome inhibitor NPI-0052 during submerged fermentation of Salinispora tropica.
    Tsueng G; Lam KS
    J Antibiot (Tokyo); 2007 Jul; 60(7):469-72. PubMed ID: 17721007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio- and chemotherapy.
    Meister N; Shalaby T; von Bueren AO; Rivera P; Patti R; Oehler C; Pruschy M; Grotzer MA
    Eur J Cancer; 2007 Aug; 43(12):1833-41. PubMed ID: 17627812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marizomib, a potent second generation proteasome inhibitor from natural origin.
    Ma L; Diao A
    Anticancer Agents Med Chem; 2015; 15(3):298-306. PubMed ID: 25403165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.
    Zeltzer PM; Boyett JM; Finlay JL; Albright AL; Rorke LB; Milstein JM; Allen JC; Stevens KR; Stanley P; Li H; Wisoff JH; Geyer JR; McGuire-Cullen P; Stehbens JA; Shurin SB; Packer RJ
    J Clin Oncol; 1999 Mar; 17(3):832-45. PubMed ID: 10071274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy.
    Song H; Bhakat R; Kling MJ; Coulter DW; Chaturvedi NK; Ray S; Joshi SS
    Biochem Biophys Res Commun; 2019 Dec; 520(2):250-256. PubMed ID: 31594641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulating native GABA
    Kallay L; Keskin H; Ross A; Rupji M; Moody OA; Wang X; Li G; Ahmed T; Rashid F; Stephen MR; Cottrill KA; Nuckols TA; Xu M; Martinson DE; Tranghese F; Pei Y; Cook JM; Kowalski J; Taylor MD; Jenkins A; Pomeranz Krummel DA; Sengupta S
    J Neurooncol; 2019 May; 142(3):411-422. PubMed ID: 30725256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
    Cowman S; Fan YN; Pizer B; Sée V
    BMC Cancer; 2019 Apr; 19(1):300. PubMed ID: 30943920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastoma.
    Keating J; Tsoli M; Hallahan AR; Ingram WJ; Haber M; Ziegler DS
    Mol Cancer Ther; 2012 Dec; 11(12):2654-63. PubMed ID: 23012247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiproliferative and proapoptotic effects of proteasome inhibitors and their combination with histone deacetylase inhibitors on leukemia cells.
    Fuchs O; Provaznikova D; Marinov I; Kuzelova K; Spicka I
    Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):62-77. PubMed ID: 19275578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma.
    Osumi AK; Mclendon RE; Tien RD; Friedman HS; Graham M; Hockenberger B; Halperin EC; Oakes WJ
    Clin Neuropathol; 1994; 13(5):281-5. PubMed ID: 7805312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
    Yamasaki K; Okada K; Soejima T; Sakamoto H; Hara J
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28012. PubMed ID: 31544362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
    Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
    J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells.
    Bangaru ML; Chen S; Woodliff J; Kansra S
    Anticancer Res; 2010 Feb; 30(2):499-504. PubMed ID: 20332461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (-)-Homosalinosporamide A and Its Mode of Proteasome Inhibition: An X-ray Crystallographic Study.
    Groll M; Nguyen H; Vellalath S; Romo D
    Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30029468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis.
    Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modern treatment strategies in medulloblastoma.
    Kühl J
    Childs Nerv Syst; 1998; 14(1-2):2-5. PubMed ID: 9548331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
    Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disappearing cystic cerebellar medulloblastoma: the ghost tumour.
    Gupta V; Kumar S; Tatke M; Singh AK; Sinha S; Singh D
    Neurol India; 2001 Sep; 49(3):291-4. PubMed ID: 11593249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.